This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
3/20/2024
Operator
Welcome to the Rani Therapeutics fourth quarter and full year 2023 financial results and corporate update conference call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session. To ensure that we have ample time to address everyone's questions during the Q&A session, we would ask for a limit of one question and one follow-up, question per person. To ask a question at the time, please press star followed by 11 on your touch tone phone. As a reminder, this call is being recorded today, Wednesday, March 20th, 2024. I would now like to turn the conference call over to Kiki Patel at Gil Martin Group.
spk14
Please go ahead.
spk06
Thank you, operator.
You're reading a preview of the RANI Q4 2023 earnings call.
Free account.
Disclaimer